HANNAH ALISON L.
Insider transactions at 3 companies
This page shows all SEC Form 4 filings attributed to HANNAH ALISON L.. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| NEO | Option Exercise | 12,254 | — | — | Jun 1, 2025 | |
| NEO | Award / Grant | 12,254 | — | — | Jun 1, 2025 | |
| RIGL | Award / Grant | 2,500 | — | — | May 23, 2025 | |
| NEO | Option Exercise | 11,336 | — | — | Aug 10, 2024 | |
| RIGL | Award / Grant | 25,000 | — | — | May 25, 2024 | |
| RIGL | Award / Grant | 25,000 | — | — | May 26, 2023 | |
| CTMX | Chief Medical Officer | Sale | 5,602 | $1.42 | $7,955 | Jul 19, 2022 |
| NEO | Award / Grant | 15,556 | — | — | Jun 10, 2022 | |
| RIGL | Award / Grant | 25,000 | — | — | May 20, 2022 | |
| CTMX | Chief Medical Officer | Award / Grant | 22,500 | — | — | Feb 2, 2022 |
| NEO | Award / Grant | 3,081 | — | — | Jun 2, 2021 | |
| RIGL | Award / Grant | 6,250 | — | — | May 19, 2021 | |
| NEO | Option Exercise | 10,000 | $7.27 | $72,700 | Aug 6, 2020 | |
| NEO | Award / Grant | 2,698 | — | — | May 28, 2020 | |
| NEO | Option Exercise | 8,333 | $9.11 | $75,914 | Sep 9, 2019 | |
| NEO | Award / Grant | 3,419 | — | — | Jun 6, 2019 | |
| NEO | Award / Grant | 15,564 | — | — | Jun 1, 2018 | |
| NEO | Option Exercise | 6,667 | $6.66 | $44,402 | Aug 9, 2017 | |
| NEO | Purchase | 20,000 | $9.19 | $183,800 | Jul 27, 2017 | |
| NEO | Option Exercise | 7,222 | — | — | May 30, 2017 | |
| NEO | Award / Grant | 2,150 | $7.15 | $15,373 | Apr 20, 2016 | |
| NEO | Purchase | 10,000 | $6.90 | $69,000 | Mar 3, 2016 |